Auf dieser Seite
IMA ImageneBio, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 5, 2026
$4,60
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$3,9452-Wochen-Tief
$9,1052-Wochen-Hoch
P/E
-0.7
EPS
$-9.64
Umsatz
$800.0K
Ihre Abzeichen
52W-Spanne
$4–$9
Analystenbewertung
STRONG BUY
Kursziel
$18
P/E
-0.7
ROE
192.1%
Nettogewinnmarge
-5668.6%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
IMA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$4.60
P/E
-0.7
EPS
$-9.64
Umsatz
$800.0K
ROE
192.1%
52W-Spanne
$4–$9
IMA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 28. Juli 2025 | 1-for-12 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$800.0K2020-12-31 → 2025-12-31
EPS$-9.642021-12-31 → 2025-12-31
Freier Cashflow·2021-12-31 → 2023-12-31
Nettogewinnmarge-5668.6%2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | IMA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -0.75-Jahres-Durchschnitt ≈-31.3 | ≈-31.3 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | IMA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Operating Margin (Betriebsgewinnmarge) | -6056.4%5-Jahres-Durchschnitt ≈-1861.0% | ≈-1861.0% | -3308.5% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | -6006.4%5-Jahres-Durchschnitt ≈-1848.5% | ≈-1848.5% | -1658.2% | Schwach | |
| Pretax Margin (Vorgewinnmarge) | -5712.4% | · | -41.8% | Schwach | |
| Net Profit Margin (Nettogewinnmarge) | -5668.6%5-Jahres-Durchschnitt ≈-1740.8% | ≈-1740.8% | 8.0% | Schwach | |
| ROA | -53.7%5-Jahres-Durchschnitt ≈-34.0% | ≈-34.0% | -32.6% | Unterdurchschnittlich | |
| ROE | 192.1%5-Jahres-Durchschnitt ≈91.1% | ≈91.1% | -15.3% | Spitzenklasse | |
| ROIC | -36.1%5-Jahres-Durchschnitt ≈-42.5% | ≈-42.5% | -23.4% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | IMA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 21.55-Jahres-Durchschnitt ≈10.6 | ≈10.6 | 4.0 | Starke Liquidität | |
| Quick Ratio | 12.05-Jahres-Durchschnitt ≈10.4 | ≈10.4 | 3.9 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | IMA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -77.1%5-Jahres-Durchschnitt ≈1.4% | ≈1.4% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -62.9%5-Jahres-Durchschnitt ≈-38.2% | ≈-38.2% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -38.6% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | IMA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.1 | ≈0.1 | 0.0 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$44.4K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-8.8%
Nächster Bericht
Nov 10, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Jul 22, 2026 | $-0.63 | $-0.90 | 30.3% |
| 31. März 2026 | Mai 6, 2026 | $-0.95 | $-0.71 | -33.7% |
| 31. Dezember 2025 | $-1.42 | $-1.46 | 2.8% | |
| 30. September 2025 | $-2.91 | $-1.29 | -125.1% | |
| 30. Juni 2025 | $-0.72 | $-1.70 | 57.6% | |
| 31. März 2025 | $-2.16 | $-2.55 | 15.1% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $800.0K | $4M | $9M | $16M | $31M | $9M | |
| R&D Expense | $29M | $32M | $60M | $64M | $47M | $45M | |
| SG&A Expense | $21M | $8M | $25M | $22M | $18M | $9M | |
| Operating Expenses | $49M | $40M | $85M | $87M | $65M | $54M | |
| Operating Income | $-48M | $-37M | $-75M | $-71M | $-34M | $-45M | |
| Interest Income | · | · | $7M | $2M | $23.0K | · | |
| Other Non-op | $717.0K | $71.0K | $-22.0K | $2M | $23.0K | $263.0K | |
| Pretax Income | $-46M | $-37M | $-68M | $-69M | · | · | |
| Income Tax | $-350.0K | $13.0K | $-162.0K | $0 | $0 | · | |
| Net Income | $-45M | $-37M | $-68M | $-69M | $-34M | $-44M | |
| EPS (Basic) | $-9.64 | $-22.10 | $-1.63 | $-1.90 | $-1.22 | · | |
| EPS (Diluted) | $-9.64 | $-22.10 | $-1.63 | $-1.90 | $-1.22 | · | |
| Shares (Basic) | 4,870,906 | 1,194,172 | 41,735,081 | 36,188,420 | 27,983,359 | · | |
| Shares (Diluted) | · | 48,258,111 | 41,735,081 | 36,188,420 | 27,983,359 | · | |
| EBITDA | $-48M | $-59M | $-75M | $-71M | $-34M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $95M | $12M | $120M | $60M | $232M | $162M | |
| Short-term Investments | $41M | $0 | $56M | $97M | · | · | |
| Prepaid Expense | $5M | $350.0K | $3M | $3M | $4M | $3M | |
| Other Current Assets | · | · | $1M | $964.0K | $629.0K | $2M | |
| Current Assets | $140M | $12M | $179M | $160M | $237M | $166M | |
| PP&E (Net) | $0 | $8.0K | $2M | $3M | $2M | $1M | |
| PP&E (Gross) | $0 | $341.0K | $5M | $5M | $4M | $2M | |
| Accum. Depreciation | $0 | $333.0K | $3M | $2M | $1M | $688.0K | |
| Other Non-current Assets | $5M | $1M | · | · | · | $872.0K | |
| Total Assets | $153M | $16M | $192M | $172M | $248M | $168M | |
| Accounts Payable | $1M | $5M | $2M | $2M | $2M | $2M | |
| Current Liabilities | $11M | $17M | $14M | $22M | $27M | $28M | |
| Capital Leases | $713.0K | $239.0K | $7M | $4M | $5M | $0 | |
| Other Non-current Liabilities | $870.0K | $0 | $950.0K | · | · | · | |
| Total Liabilities | $20M | $17M | $22M | $25M | $40M | $63M | |
| Common Stock | · | $48.0K | $48.0K | $36.0K | $36.0K | $3.0K | |
| Paid-in Capital | $363M | $2M | $452M | $362M | $353M | $10M | |
| Retained Earnings | $-230M | $-180M | $-282M | $-214M | $-145M | $-111M | |
| AOCI | $87.0K | $-2M | $-48.0K | $-763.0K | · | · | |
| Stockholders' Equity | $133M | $-161M | $-126M | $147M | $208M | $-101M | |
| Liabilities + Equity | $153M | $16M | $192M | $172M | $248M | $168M | |
| Shares Outstanding | · | 48,258,111 | 48,258,111 | 36,257,493 | 35,975,034 | 3,096,903 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $400.0K | $1M | · | · | · | · | |
| Stock-based Comp | $15M | $0 | $8M | $8M | $5M | $2M | |
| Deferred Tax | $0 | $0 | · | · | · | · | |
| Restructuring | · | $4M | · | · | · | · | |
| Other Non-cash | $-18M | · | · | · | · | · | |
| Operating Cash Flow | $-48M | $-21M | $-80M | $-74M | $-60M | $-38M | |
| CapEx | · | · | $414.0K | $1M | $2M | $766.0K | |
| Investing Cash Flow | $-6M | $11M | $64M | $-99M | $-2M | $3M | |
| Debt Issued | $15M | $8M | · | · | · | · | |
| Net Debt Issued | $15M | · | · | · | · | · | |
| Stock Issued | · | · | $37M | · | · | · | |
| Stock Repurchased | · | · | $663.0K | · | · | · | |
| Net Stock Activity | · | · | $-663.0K | · | · | · | |
| Financing Cash Flow | $135M | $7M | $76M | $1M | $132M | $116M | |
| Net Change in Cash | $82M | $-3M | · | · | · | · | |
| Taxes Paid | $23.0K | $221.0K | · | · | · | · | |
| Free Cash Flow | · | · | $-80M | $-76M | $-62M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -6056.4% | · | -823.3% | -454.0% | -110.2% | · | |
| Net Margin | -5668.6% | · | -744.2% | -440.3% | -110.1% | · | |
| Pretax Margin | -5712.4% | · | -745.9% | · | · | · | |
| EBITDA Margin | -6006.4% | · | -823.3% | -454.0% | -110.2% | · | |
| ROA | -53.7% | -29.5% | -37.4% | -32.7% | -16.4% | · | |
| ROE | 192.1% | 367.1% | -41.9% | -45.0% | -16.6% | · | |
| ROIC | -36.1% | -47.0% | -44.3% | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 12.5 | 11.8 | 12.6 | 7.4 | 8.7 | · | |
| Quick Ratio | 12.0 | 11.5 | 12.4 | 7.3 | 8.5 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.1 | 0.1 | 0.1 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $2.61 | $3.52 | $4.05 | $5.78 | · | |
| Revenue / Share | · | · | $0.22 | $0.43 | · | · | |
| Cash Flow / Share | · | $-0.95 | $-1.91 | $-2.05 | · | · | |
| Cash / Share | · | $0.82 | $2.48 | $1.65 | $6.45 | · | |
| EPS (TTM) | $-9.64 | $-22.10 | $-1.63 | $-1.90 | $-1.22 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -77.1% | -61.8% | -41.3% | -49.6% | 237.0% | · | |
| Revenue CAGR 3Y | -62.9% | -51.7% | -0.12% | · | · | · | |
| Revenue CAGR 5Y | -38.6% | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $800.0K | $4M | $9M | $16M | $31M | · | |
| Net Income TTM | $-45M | $-37M | $-68M | $-69M | $-34M | · | |
| Market Cap | · | $950M | $1.14B | $1.16B | $5.41B | · | |
| P/E | -0.7 | -0.9 | -14.5 | -16.8 | -123.3 | · | |
| P/S | · | 271.3 | 124.5 | 74.1 | 174.7 | · | |
| P/B | · | 7.5 | 6.7 | 7.9 | 26.0 | · | |
| P / Tangible Book | · | · | · | 7.9 | 26.0 | · | |
| P / Cash Flow | · | -20.6 | -14.3 | -15.6 | -89.8 | · | |
| P / FCF | · | · | -14.2 | -15.3 | -87.3 | · | |
| Earnings Yield | -139.7% | -112.3% | -6.9% | -5.9% | -0.81% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | $800.0K | $0 | $4M | · | · | $658.0K | $1M | $2M | $5M | $5M | $6M | |
| R&D Expense | $7M | $6M | $5M | $16M | $6M | $4M | $9M | $4M | $10M | $10M | $14M | $15M | $15M | $16M | $16M | $19M | |
| SG&A Expense | $5M | $6M | $-370.0K | $11M | $2M | $3M | $-5M | $2M | $5M | $6M | $8M | $6M | $5M | $5M | $5M | $5M | |
| Operating Expenses | $12M | $12M | $3M | $27M | $7M | $7M | $915.0K | $6M | $16M | $18M | $23M | $21M | $20M | $21M | $21M | $24M | |
| Operating Income | $-12M | $-12M | $-2M | $-27M | $-7M | $-6M | $-915.0K | $-2M | $-16M | $-18M | $-22M | $-20M | $-18M | $-16M | $-15M | $-18M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | $2M | $1M | $730.0K | $967.0K | $550.0K | |
| Other Non-op | $374.0K | $341.0K | $-7M | $2M | $9.0K | $-5.0K | $1M | $-1M | $235.0K | $-7.0K | $-580.0K | $-2.0K | $-6.0K | $566.0K | $1M | $538.0K | |
| Pretax Income | $-10M | $-11M | $-10M | $-25M | $-8M | $-6M | $-4M | $-3M | $-14M | $-16M | $-20M | $-17M | $-17M | $-14M | · | · | |
| Income Tax | $16.0K | $10.0K | $-319.0K | $-74.0K | $15.0K | $28.0K | $-76.0K | $0 | $62.0K | $27.0K | · | · | · | · | · | · | |
| Net Income | $-10M | $-11M | $-7M | $-25M | $-8M | $-6M | $-5M | $-3M | $-6M | $-22M | $-19M | $-17M | $-17M | $-14M | $-14M | $-17M | |
| EPS (Basic) | $-0.63 | $-0.95 | $-6.49 | $-2.91 | $-4.46 | $-3.80 | $-18.91 | $-2.58 | $-0.28 | $-0.33 | $-0.40 | $-0.40 | $-0.44 | $-0.39 | $-0.38 | $-0.48 | |
| EPS (Diluted) | $-0.63 | $-0.95 | $-6.49 | $-2.91 | $-4.46 | $-3.80 | $-18.91 | $-2.58 | $-0.28 | $-0.33 | $-0.40 | $-0.40 | $-0.44 | $-0.39 | $-0.38 | $-0.48 | |
| Shares (Basic) | · | 11,211,268 | · | 8,526,781 | 48,258,111 | 1,409,963 | · | 1,400,557 | 48,258,111 | 48,258,111 | · | 43,437,844 | 39,292,710 | 36,257,493 | · | 36,257,074 | |
| Shares (Diluted) | 16,161,721 | 11,211,268 | · | · | 2,406,516 | 2,404,832 | · | 48,258,111 | 48,258,111 | 48,258,111 | · | 43,437,844 | 39,292,710 | 36,257,493 | · | 36,257,074 | |
| EBITDA | $-12M | $-12M | · | $-27M | $-9M | $-11M | · | $-12M | $-16M | $-18M | · | $-20M | $-18M | $-16M | · | $-18M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $95M | $76M | $95M | $103M | $58M | $37M | $12M | $45M | $44M | $53M | $120M | $121M | $71M | $29M | $60M | $67M | |
| Short-term Investments | $41M | $41M | $41M | $39M | $37M | $77M | $0 | $93M | $101M | $104M | $56M | $76M | $86M | $108M | $97M | $107M | |
| Prepaid Expense | $5M | $5M | $5M | $5M | $3M | $3M | $350.0K | $4M | $4M | $4M | $3M | $4M | $3M | $3M | $3M | $4M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $1M | $731.0K | $1M | $964.0K | $1M | |
| Current Assets | $141M | $122M | $140M | $148M | $99M | $117M | $12M | $142M | $149M | $161M | $179M | $201M | $161M | $141M | $160M | $178M | |
| PP&E (Net) | · | · | $0 | $1.0K | $419.0K | $506.0K | $8.0K | $682.0K | $772.0K | $864.0K | $2M | $3M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | · | · | $0 | · | · | · | $341.0K | · | · | · | $5M | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | · | · | $0 | · | · | · | $333.0K | · | · | · | $3M | $3M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | · | · | $5M | $5M | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Total Assets | $152M | $137M | $153M | $161M | $126M | $131M | $16M | $149M | $157M | $173M | $192M | $215M | $172M | $152M | $172M | $190M | |
| Accounts Payable | $977.0K | $568.0K | $1M | $2M | $512.0K | $805.0K | $5M | $2M | $1M | $2M | $2M | $4M | $2M | $3M | $2M | $2M | |
| Current Liabilities | $7M | $7M | $11M | $11M | $7M | $9M | $17M | $9M | $8M | $10M | $14M | $19M | $12M | $14M | $22M | $25M | |
| Capital Leases | $0 | $110.0K | $713.0K | $1M | $2M | $3M | $239.0K | $4M | $5M | $6M | $7M | $8M | $3M | $3M | $4M | $4M | |
| Other Non-current Liabilities | $838.0K | $881.0K | $870.0K | $1M | $1M | $1M | $0 | $1M | $1M | $964.0K | · | · | · | · | · | · | |
| Total Liabilities | $10M | $13M | $20M | $21M | $10M | $13M | $17M | $15M | $15M | $17M | $22M | $28M | $15M | $17M | $25M | $32M | |
| Common Stock | · | · | · | · | $48.0K | $48.0K | · | $48.0K | $48.0K | $48.0K | $48.0K | $44.0K | $42.0K | $36.0K | $36.0K | $36.0K | |
| Paid-in Capital | $393M | $364M | $363M | $363M | $459M | $458M | $2M | $456M | $455M | $454M | $452M | $418M | $403M | $364M | $362M | $360M | |
| Retained Earnings | $-251M | $-241M | $-230M | $-223M | $-343M | $-340M | $-180M | $-322M | $-312M | $-299M | $-282M | $-263M | $-246M | $-228M | $-214M | $-200M | |
| AOCI | $-51.0K | $-17.0K | $87.0K | $94.0K | $65.0K | $99.0K | $-2M | $240.0K | $-350.0K | $-313.0K | $-48.0K | $-290.0K | $-456.0K | $-491.0K | $-763.0K | $-1M | |
| Stockholders' Equity | $142M | $123M | $133M | $140M | $116M | $118M | $-161M | $134M | $143M | $155M | $170M | $155M | $157M | $135M | $147M | $159M | |
| Liabilities + Equity | $152M | $137M | $153M | $161M | $126M | $131M | $16M | $149M | $157M | $173M | $192M | $215M | $172M | $152M | $172M | $190M | |
| Shares Outstanding | · | · | · | · | 48,258,111 | 48,258,111 | · | 48,258,111 | 48,258,111 | 48,258,111 | 48,258,111 | 44,104,672 | 42,299,478 | 36,257,493 | 36,257,493 | 36,257,493 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $0 | $0 | $393.0K | $2.0K | $2.0K | $2.0K | $18.0K | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $911.0K | $876.0K | $51.0K | $14M | $458.0K | $57.0K | $0 | $-3M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Restructuring | · | · | · | · | $309.0K | $1M | · | $812.0K | $683.0K | $3M | · | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-15M | $-7M | $-27M | $-3M | $-7M | $-3M | $13M | $-13M | $-18M | $-22M | $-20M | $-18M | $-20M | $-18M | $-17M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $262.0K | $0 | $0 | $152.0K | $231.0K | $1M | |
| Investing Cash Flow | $-346.0K | $-440.0K | $-1M | $-37M | $25M | $0 | $103.0K | $56M | $4M | $-49M | $20M | $32M | $23M | $-11M | $10M | $36M | |
| Debt Issued | · | · | $0 | $0 | · | · | $8M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $-123.0K | · | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | · | · | |
| Financing Cash Flow | $28M | $-3M | $0 | $122M | $13M | $27.0K | $7M | · | · | · | $60.0K | $39M | · | · | $1.0K | $24.0K | |
| Net Change in Cash | $19M | $-18M | $-9M | $97M | $1M | $-7M | $4M | · | · | · | · | · | · | · | · | · | |
| Taxes Paid | · | · | $9.0K | · | · | · | $220.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-20M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | -1645.8% | -922.6% | -292.0% | · | -279.2% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | -1463.5% | -854.0% | -267.6% | · | -270.8% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | -1645.8% | -922.6% | -292.0% | · | -279.2% | |
| ROA | -7.3% | -7.9% | · | -16.0% | -1.9% | -5.7% | · | -5.6% | -8.3% | -9.9% | · | -8.6% | -8.9% | -7.5% | · | -7.7% | |
| ROE | -7.9% | -8.8% | · | -18.1% | -2.1% | -6.3% | · | -7.1% | -9.2% | -11.1% | · | -11.0% | -10.3% | -8.7% | · | -9.6% | |
| ROIC | -8.3% | -9.8% | · | -19.0% | -7.6% | -9.2% | · | -9.2% | -11.1% | -11.8% | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 21.5 | 18.4 | · | 13.2 | 13.5 | 13.3 | · | 15.3 | 18.2 | 15.8 | · | 10.4 | 13.4 | 10.1 | · | 7.1 | |
| Quick Ratio | 20.7 | 17.7 | · | 12.8 | 13.1 | 13.0 | · | 14.9 | 17.7 | 15.5 | · | 10.2 | 13.1 | 9.9 | · | 7.0 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | $2.40 | $2.45 | · | $2.78 | $2.96 | $3.22 | · | $3.52 | $3.70 | $3.72 | · | $4.38 | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | · | · | $0.03 | $0.05 | $0.15 | · | $0.18 | |
| Cash Flow / Share | · | $-1.32 | · | · | · | $-0.22 | · | · | · | $-0.38 | · | · | · | $-0.55 | · | · | |
| Cash / Share | · | · | · | · | $1.21 | $0.76 | · | $0.94 | $0.92 | $1.10 | · | $2.75 | $1.68 | $0.81 | · | $1.85 | |
| EPS (TTM) | $-10.98 | $-14.81 | · | $-30.08 | $-29.75 | $-25.57 | · | $-3.59 | $-1.41 | $-1.57 | · | $-1.61 | $-1.69 | $-1.82 | · | $-1.28 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $800.0K | $800.0K | · | $800.0K | $4M | · | · | · | $9M | $9M | · | $14M | $19M | $18M | · | $30M | |
| Net Income TTM | $-52M | $-50M | · | $-43M | $-22M | $-20M | · | $-51M | $-65M | $-76M | · | $-63M | $-63M | $-66M | · | $-52M | |
| Market Cap | · | · | · | · | $776M | $741M | · | $1.00B | $956M | $822M | · | $2.29B | $3.33B | $1.50B | · | $1.54B | |
| P/E | -0.5 | -0.3 | · | -0.3 | -0.5 | -0.6 | · | -5.8 | -14.0 | -10.9 | · | -32.3 | -46.6 | -22.7 | · | -33.3 | |
| P/S | · | · | · | · | 180.5 | · | · | · | 104.3 | 89.8 | · | 164.3 | 173.7 | 85.5 | · | 50.8 | |
| P/B | · | · | · | · | 6.7 | 6.3 | · | 7.5 | 6.7 | 5.3 | · | 14.8 | 21.2 | 11.1 | · | 9.7 | |
| P / Tangible Book | · | · | · | · | 6.7 | 6.3 | · | 7.5 | 6.7 | 5.3 | · | 14.8 | 21.2 | 11.1 | · | 9.7 | |
| P / Cash Flow | · | · | · | · | · | -70.2 | · | · | · | -44.9 | · | · | · | -75.9 | · | · | |
| Earnings Yield | -186.1% | -296.2% | · | -369.1% | -185.0% | -166.5% | · | -17.3% | -7.1% | -9.2% | · | -3.1% | -2.1% | -4.4% | · | -3.0% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $800.0K | $4M | $9M | $16M | $31M |
| Betriebsgewinnmarge % | -6056.4% | · | -823.3% | -454.0% | -110.2% |
| Nettoergebnis | $-45M | $-37M | $-68M | $-69M | $-34M |
| Verwässerte EPS | $-9.64 | $-22.10 | $-1.63 | $-1.90 | $-1.22 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 12.5 | 11.8 | 12.6 | 7.4 | 8.7 |
| Quick Ratio | 12.0 | 11.5 | 12.4 | 7.3 | 8.5 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | · | · | $-80M | $-76M | $-62M |
Institutionelle Eigentümer (13F) 36 Einreicher · $38.4M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
36
Gehaltener Wert
$38.4M
Neue Positionen
4
Geschlossene Positionen
8
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 4 (-3 vs. Vorquartal) | 8 (+1 vs. Vorquartal) | 9 (-8 vs. Vorquartal) | 12 (+6 vs. Vorquartal) | +879K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BVF INC/IL | $6.549.012 | 1.110.002 | 17,04% | Aktien |
| Blue Owl Capital Holdings LP | $5.414.383 | 917.692 | 14,09% | Aktien |
| ORBIMED ADVISORS LLC | $5.364.687 | 909.269 | 13,96% | Aktien |
| Cable Car Capital, LP | $4.611.434 | 781.599 | 12,00% | Aktien |
| Omega Fund Management, LLC | $2.686.630 | 455.361 | 6,99% | Aktien |
| RTW INVESTMENTS, LP | $1.973.226 | 334.445 | 5,13% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.891.056 | 320.518 | 4,92% | Aktien |
| Trails Edge Capital Partners, LP | $1.663.824 | 282.004 | 4,33% | Aktien |
| VANGUARD GROUP INC | $1.642.200 | 238.000 | 4,27% | Aktien |
| BML Capital Management, LLC | $1.184.307 | 200.730 | 3,08% | Aktien |
| Monashee Investment Management LLC | $1.134.830 | 192.344 | 2,95% | Aktien |
| BlackRock, Inc. | $797.030 | 135.090 | 2,07% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $512.887 | 86.930 | 1,33% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $393.329 | 66.666 | 1,02% | Aktien |
| CITADEL ADVISORS LLC | $328.099 | 55.610 | 0,85% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $315.755 | 53.512 | 0,82% | Aktien |
| NEA Management Company, LLC | $295.030 | 50.005 | 0,77% | Aktien |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $295.000 | 50.000 | 0,77% | Aktien |
| HSBC HOLDINGS PLC | $208.449 | 34.228 | 0,54% | Aktien |
| Sofinnova Investments, Inc. | $188.116 | 31.884 | 0,49% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $162.103 | 27.475 | 0,42% | Aktien |
| Rangeley Capital, LLC | $118.531 | 20.090 | 0,31% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $117.410 | 19.900 | 0,31% | Aktien |
| Aldebaran Capital, LLC | $106.932 | 18.124 | 0,28% | Aktien |
| Shay Capital LLC | $106.672 | 18.080 | 0,28% | Aktien |
| MORGAN STANLEY | $98.400 | 16.678 | 0,26% | Aktien |
| GOLDMAN SACHS GROUP INC | $91.362 | 15.485 | 0,24% | Aktien |
| NORTHERN TRUST CORP | $66.499 | 11.271 | 0,17% | Aktien |
| BARCLAYS PLC | $63.702 | 10.797 | 0,17% | Aktien |
| UBS Group AG | $40.586 | 6.879 | 0,11% | Aktien |
| Tower Research Capital LLC (TRC) | $3.983 | 675 | 0,01% | Aktien |
| Vanguard Global Advisers, LLC | $3.552 | 602 | 0,01% | Aktien |
| Caitong International Asset Management Co., Ltd | $2.738 | 464 | 0,01% | Aktien |
| NewEdge Advisors, LLC | $944 | 160 | 0,00% | Aktien |
| JPMORGAN CHASE & CO | $425 | 70 | 0,00% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $142 | 24 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP VI LLC, OrbiMed Genesis GP LLC, ORBIMED CAPITAL LLC ×7 Einreichungen | 29. April 2026 | 13,10% | Änderung | · | SEC |
| Omega Fund VI, L.P., Omega Fund VI GP, L.P., Omega Fund VI GP Manager, Ltd., Claudio Nessi, Otello Stampacchia | 21. April 2026 | 8,40% | Erste Einreichung | Passive Anlage | SEC |
| Atlas Venture Fund X, L.P., ATLAS VENTURE ASSOCIATES X, L.P., Atlas Venture Associates X, LLC, Atlas Venture Fund XI, L.P., Atlas Venture Associates XI, L.P., Atlas Venture Associates XI, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC ×2 Einreichungen | 29. Juli 2025 | 2,10% | Änderung | M&A / Verkauf | SEC |
| BML Investment Partners, L.P., Leonard Braden Michael ×2 Einreichungen | 28. Juli 2025 | 1,90% | Änderung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 23 Insider · 12 Führungskräfte · 13 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Kristin Yarema | Chief Executive Officer | 14. August 2026 A | 493.705 | 0 | 0 | $0 |
| Mark Manfredi | President & CEO | 1. Februar 2024 A | · | 0 | 0 | $0 |
| Yanina Grant-Huerta | Chief Financial Officer | 14. August 2026 A | 104.000 | 0 | 0 | $0 |
| Jotin Marango | Chief Financial Officer | 25. Juli 2025 D | 11.146 | 0 | 0 | $0 |
| Robert B Lally | Principal Accounting Officer | 17. Juli 2026 S | 55.582 | 0 | 2 | $-17.334 |
| Erin Butler | Principal Accounting Officer | 30. Dezember 2025 A | 25.551 | 0 | 0 | $0 |
| Yufang Lu | Chief Medical Officer | 25. Juli 2025 A | · | 0 | 0 | $0 |
| Caroline Germa | Chief Medical Officer | 1. März 2024 A | · | 0 | 0 | $0 |
| Jeffrey Ecsedy | Chief Development Officer | 1. Februar 2024 A | · | 0 | 0 | $0 |
| Xiaoyan Michelle Zhang | Chief Scientific Officer | 3. Januar 2023 A | 44.475 | 0 | 0 | $0 |
| Sergio L. Santillana | Chief Medical Officer | 3. Januar 2023 A | · | 0 | 0 | $0 |
| Maude Tessier | Chief Business Officer | 2. Februar 2022 A | 100.578 | 0 | 0 | $0 |
| David P Bonita | Direktor | 16. Juni 2026 A | 287.885 | 0 | 0 | $0 |
| Jonathan Jian Wang | Direktor | 16. Juni 2026 A | 971.173 | 0 | 0 | $0 |
| Otello Stampacchia | Direktor | 16. Juni 2026 A | 454.982 | 0 | 0 | $0 |
| Joseph P Slattery | Direktor | 16. Juni 2026 A | 16.000 | 1 | 0 | $95.840 |
| Stephen Hui Wang | Direktor | 18. Dezember 2025 A | 12.535 | 0 | 0 | $0 |
| Maria Koehler | Direktor | 7. Juni 2024 A | · | 0 | 0 | $0 |
| Richard Wooster | Direktor | 7. Juni 2024 A | · | 0 | 0 | $0 |
| Iain D. Dukes | Direktor | 7. Juni 2024 A | · | 0 | 0 | $0 |
| Owen Hughes | Direktor | 7. Juni 2024 A | · | 0 | 0 | $0 |
| FORMELA JEAN FRANCOIS | Direktor | 7. Juni 2024 A | 1.241.935 | 0 | 0 | $0 |
| Ronald C Renaud JR | Direktor | 9. Juni 2022 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 3 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
IMA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 8 Analysten
KAUF
Median-Ziel
$24.00
+421,7%
3 37,5%
Starker Kauf
3 37,5%
Kauf
1 12,5%
Halten
0 0,0%
Verkauf
1 12,5%
Starker Verkauf
12-Monats-Kursziel
3 Analysten · 2026-09-30Mittelwert-Ziel $18.00 +291,3%
Jetzt
Aktueller Preis $4.60
Tief$2.00
Mittelwert$18.00
Hoch$28.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| IMA | · | -0.7 | -77.1% | -5668.6% | 192.1% | · |
| HYPD | $31M | -0.4 | 1318.8% | -5570.6% | -115.6% | 62.7% |
| TLPH | $56M | · | · | -51035.7% | -120.8% | · |
| SCYX | $28M | -3.7 | 450.0% | -41.8% | -18.4% | · |
| BSEM | · | · | · | · | · | · |
| FLNA | · | · | · | · | -112.1% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 5, 2026